Applications Published 6 February 2002

Published: 1-Sep-2002

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).


The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).

  • Anti-nausea compsns and methods
    KV Pharmaceutical 1176948*

  • Lipid particles on the basis of mixtures of liquid and solid lipids and a method for producing the same
    Pharmasol 1176949*

  • A method and devide for enclosing application of a coating on a tablet, capsule or pill, or the like
    Lilleblad, Frederik 1176950*

  • Drug delivery device
    US Dermatologies 1176951*

  • 2R,4S-hydroxyitraconazole isomers
    Sepracor 1176952*

  • Treatment of a variety of pathological conditions, including spasticity and convulsions, by effecting modulation of CNS activity with isovaleramide, isovaleric acid, or a related compound
    NPS Pharmaceutical 1176953*

  • Neuroprotective compsn and uses thereof
    Gestilab 1176954*

  • Cardioprotective compsn and uses thereof
    Gestilab 1176955*

  • Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
    Texas Biotechnology 1176956*

  • Method for treating abnormal cell proliferation
    Aventis Pharma 1176957*

  • Novel catechols as antimicrobial agents
    Merck 1176958*

  • Novel prolines as antimicrobial agents
    Merck; Cubist Pharmaceuticals 1176959*

  • Synergistic combination comprising rofulimast and a PD-3 inhibitor
    Byk Gulden Lomberg Chemische Fabrik 11769608*

  • Nicotine delivery systems
    Micap 1176961*

  • Liposome compsn for improved drug retention
    Alza Corp 1176962*

  • Use of dopamine D3 receptor ligands for producing medicaments for treating kidney disorders
    BASF 1176963*

  • Compsns and uses of ET743 for treating cancer
    Pharma Mar 1176964*

  • Antisense modulation of FAS mediated signal
    Isis Pharmaceuticals 1176965*

  • Oligonucleotide and its use to induce an immune response
    The Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services 1176966*

  • Selenium-coated prodrugs for cancer therapy
    Anticancer 1176968*

  • Substitution infusion fluid and citrate anticoagulation
    Chang, Pe Chou 1176969*

  • Use of Phyllanthus for treating chronic inflammatory and fibrotic proceses
    CMI-Centres for Medical Innovation 1176971*

  • Use of Phyllanthus for targeted stimulation of the immune system
    CMI-Centres for Medical Innovation 1176972*

  • Dietetic use of Cynaria cardunculus and Silybum marianum oils
    Julia, Jean 1176973*

  • Compsns and methods for treating benign prostatic hyperplasia using tocotrienols
    Lipogenics 1176974*

  • Pharmacokinetic and pharmacodynamic modelling of erythropoietin administration
    Ortho-McNeil Pharmaceuticals 1176975*

  • Gonadotrophins
    Applied Research Systems 1176976*

  • Ceruloplasmin and an antioxidant compns comprising the same and their uses as neuroprotective agents
    Gestilab 1176977*

  • HIV immunogenic compsns and methods
    The Immune Response Corp 1176978*

  • High concentration immunoglobulin preparation and method for its production
    CSL 1176979*

  • CCR4 antagonists in sepsis
    Applied Research Systems 1176980*

  • Treatment of autoimmune diseases with antagonists which bind to B cell surface markers Genentech; Idec
    Pharmaceuticals 1176981*

  • Prucalopride oral solution
    Janssen Pharmaceutica 1176982*

  • Hyperbranched polymeric micelles for encapsulation and delivery of hydrophobic molecules
    Rutgers, the State University 1176983*

  • Medicament vehicle for the controlled administration of an active agent, produced from lipid matrix-medicament conjugates
    Pharmasol 1176984*

  • Enzymatically activated polymeric drug conjugates
    Vectramed 1176985*

  • Differentiation of monocytes into functional dendritic cells
    Edelson, Richard 1176986*

  • Short-chain peptide dye conjugates used as contrast agents for optical diagnostics
    Institut fuer Diagnostikforschung an der Freien Universitaet Berlin 1176987*

  • Radioactive cisplatin in the treatment of cancer
    Isotope Solutions 1176988*

  • A process for the purification of diacerein
    Synteco 1177164*

  • Process for preparing (1R,2S,4R)-(-)-2-(2'-N,N-dimethylamino-ethoxy)-2-phenyl-[1,7,7-trimethyl]-bicyclo 2.2.1]heptane and pharmaceuticaly acceptable salts thereof
    Egis Gyogszergyar 1177166*

  • Caspase inhibitors and the use thereof
    Cytovia 1177168*

  • 6-[(aryl and heteroaryl)oxy]methyl]naphthalene-2-carboximidamide derivatives, preparation and therapeutic use thereof
    Sanofi-Synthelabo 1177169*

  • Substituted indole sulfonamides as antiviral agents
    Bayer 1177171*
  • You may also like